Asebio Launches an application that collects 365 projects of biotechnology linked to ephemerides of 2014

Already is possible to download in the shop Google Play the application Investbio, developed by the Spanish Association of Bioempresas (Asebio), a digital calendar with 365 projects biotecnológicos innovative linked each day to a commemoration or ephemeris.

This free mobile application will allow to spread the meaning and contributions of the biotechnology to those investors interested in the field of the sciences of the life, as well as to those that desconozcan this type of technologies.

Investbio Is available in the market store of mobiles Android, and in the next days in the market store of iPhone and Blackberry and will allow to the user receive each day, during 2014 impacts in format flash on the advances and news more attractor trucks in relation to the new technologies, products, projects, etc., of the sector biotecnológico tied to ephemerides.

Although they exist two modalities of access (both free), the version Premium demands a register and allows to the user receive personalised information on the projects of his interest. This version is especially designed for investors, financial advisers, business angels, main risk, crowdfunding, family office, etc. Precisely to give to know Investbio to the financial community, Asebio will be present in the next months in the majority of the events and forums of investment of the country.

The investment in investigation and technology in Europe is a very effective road to settle down private investment and has contributed to create incentives for the attraction of investment and the generation, therefore, of qualified employment. However, had to fundamentally to the fault of bottoms to fund these activities, exist numerous competitive projects that have not been able to develop and that, consistently, have done to lose big opportunities that neither Europe neither Spain can allow, especially in a circumstantial stage of fault of capital for all the economic sectors.

In the bioempresas the fault of bottoms constitutes a recurrent barrier to fund his activities. No in vain, they need to fund diverse stages of his development like company that cross different stadiums. If to this adds a financial crisis and of credit like the current, the final result is that the operations postpone indefinitely. These delays in himself same can cause no already only a descent of the activity of the company or a restructuring, but the simple disappearance or closing of the same.

Thus, are necessary actions that improve a possible road of financials for the sector biotecnológico. This is an important step of Asebio that will continue with a solid strategy of approximation to the sector investor mainly private, with the end to design some surroundings that propicie opportunities of financials.